- Home
- GPCR vs ARMN Comparison
GPCR vs ARMN Comparison
Compare GPCR & ARMN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GPCR
- ARMN
- Stock Information
- Founded
- GPCR 2016
- ARMN 1992
- Country
- GPCR United States
- ARMN Canada
- Employees
- GPCR N/A
- ARMN N/A
- Industry
- GPCR
- ARMN
- Sector
- GPCR
- ARMN
- Exchange
- GPCR Nasdaq
- ARMN Nasdaq
- Market Cap
- GPCR 1.1B
- ARMN 1.3B
- IPO Year
- GPCR 2023
- ARMN N/A
- Fundamental
- Price
- GPCR $17.59
- ARMN $7.12
- Analyst Decision
- GPCR Strong Buy
- ARMN
- Analyst Count
- GPCR 7
- ARMN 0
- Target Price
- GPCR $76.17
- ARMN N/A
- AVG Volume (30 Days)
- GPCR 734.9K
- ARMN 1.0M
- Earning Date
- GPCR 08-11-2025
- ARMN 08-07-2025
- Dividend Yield
- GPCR N/A
- ARMN N/A
- EPS Growth
- GPCR N/A
- ARMN 28.55
- EPS
- GPCR N/A
- ARMN 0.15
- Revenue
- GPCR N/A
- ARMN $560,512,000.00
- Revenue This Year
- GPCR N/A
- ARMN $49.45
- Revenue Next Year
- GPCR N/A
- ARMN $8.19
- P/E Ratio
- GPCR N/A
- ARMN $44.84
- Revenue Growth
- GPCR N/A
- ARMN 22.28
- 52 Week Low
- GPCR $13.22
- ARMN $3.29
- 52 Week High
- GPCR $45.37
- ARMN $7.72
- Technical
- Relative Strength Index (RSI)
- GPCR 31.53
- ARMN 52.87
- Support Level
- GPCR $17.45
- ARMN $6.83
- Resistance Level
- GPCR $18.78
- ARMN $7.31
- Average True Range (ATR)
- GPCR 0.82
- ARMN 0.27
- MACD
- GPCR 0.00
- ARMN -0.05
- Stochastic Oscillator
- GPCR 5.00
- ARMN 34.95
About GPCR Structure Therapeutics Inc.
Structure Therapeutics Inc is a clinical-stage biopharmaceutical company developing novel oral small-molecule therapeutics to treat a wide range of chronic diseases with unmet medical needs. Its differentiated technology platform leverages both structure-based drug discovery and expertise in computational chemistry to discover and develop small molecule therapeutics against G-protein coupled receptors (GPCRs). The group operates and manages its business as one reportable and operating segment, which is the business of research and development of medicines that target chronic diseases with unmet medical needs.
About ARMN Aris Mining Corporation
Aris Mining Corp is engaged in the acquisition, exploration, development, and operation of gold properties in Colombia, Guyana, and Canada. It owns and operates its Segovia Operations, Soto Norte Project and Marmato Mine in Colombia, the Toroparu Project in Guyana, and the Juby Project in Ontario, Canada. The company generates revenue from the sale of gold and silver.